TIL insider filings
Instil Bio, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-12. Screen TIL transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for TIL between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Instil Bio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Matcham George — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Binder Gwendolyn — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Gibson Neil W — Director | Grant/award (A): 0 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | McGaughy R Kent Jr — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Laumas Sandeep — CFO and CBO | Option exercise (M): 17,000 @ $11.60 · Option exercise (M): 13,000 @ $12.68 · Sale (S): 17,539 @ $23.04 · Sale (S): 12,461 @ $23.88 · Option exercise (M): 17,000 (derivative) @ $0 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Binder Gwendolyn — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Matcham George — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Gibson Neil W — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | McGaughy R Kent Jr — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2025-04-28 | 4 | Crouch Bronson — CEO and Chairman, Director, 10% owner | Grant/award (A): 105,157 (derivative) @ $0 | EDGAR |
| 2025-04-28 | 4 | Laumas Sandeep — CFO and CBO | Grant/award (A): 44,851 (derivative) @ $0 | EDGAR |
| 2024-09-23 | 4 | Crouch Bronson — CEO and Chairman, Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-09-23 | 4 | Laumas Sandeep — CFO and CBO | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Matcham George — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Binder Gwendolyn — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Gibson Neil W — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | McGaughy R Kent Jr — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Crouch Bronson — CEO and Chairman, Director, 10% owner | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Laumas Sandeep — CFO and CBO | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | Binder Gwendolyn — Director | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | Matcham George — Director | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | Nielsen Jack — Director | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | Gibson Neil W — Director | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | McGaughy R Kent Jr — Director | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Crouch Bronson — CEO and Chairman, Director, 10% owner | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4/A | Crouch Bronson — CEO and Chairman, Director, 10% owner | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Laumas Sandeep — CFO and CBO | Grant/award (A): 415,000 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4/A | Laumas Sandeep — CFO and CBO | Grant/award (A): 234,000 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Ray Sumita — Chief Legal and Admin Officer | Grant/award (A): 415,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-09-06 | 4 | MOORE TIMOTHY L. — Chief Operating Officer | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Chiruvolu Vijay — Chief Technical Officer | Grant/award (A): 154,237 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Binder Gwendolyn — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Matcham George — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Nielsen Jack — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Gibson Neil W — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | McGaughy R Kent Jr — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-03-17 | 4 | McGaughy R Kent Jr — Director | Other (J): 260,323 @ $0 | EDGAR |
| 2022-03-07 | 4 | Roberts Zachary — Chief Medical Officer | Grant/award (A): 245,000 (derivative) @ $8.62 | EDGAR |
| 2022-03-07 | 4 | Crouch Bronson — CEO and Chairman, Director, 10% owner | Grant/award (A): 750,000 (derivative) @ $8.62 | EDGAR |
| 2022-03-07 | 4 | Chiruvolu Vijay — Chief Technical Officer | Grant/award (A): 257,000 (derivative) @ $8.62 | EDGAR |
| 2022-03-07 | 4 | Laumas Sandeep — CFO and CBO | Grant/award (A): 234,000 (derivative) @ $8.62 | EDGAR |
| 2021-10-08 | 4 | Roberts Zachary — Chief Medical Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2021-09-13 | 4 | Roberts Zachary — Chief Medical Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | Chiruvolu Vijay — Chief Technical Officer | Grant/award (A): 154,237 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | Roberts Zachary — Chief Medical Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | Crouch Bronson — CEO and Chairman, Director, 10% owner | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | Laumas Sandeep — CFO and CBO | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | Shah Nimish P — Director | Conversion (C): 5,100,866 · Conversion (C): 510,030 · Conversion (C): 430,431 · Conversion (C): 43,033 · Conversion (C): 480,716 · Purchase (P): 104,640 @ $20 · +9 more | EDGAR |
| 2021-03-25 | 4 | Nielsen Jack — Director | Conversion (C): 11,709,696 · Conversion (C): 477,091 · Purchase (P): 300,000 @ $20 · Conversion (C): 9,758,080 (derivative) @ $0 · Conversion (C): 397,576 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | McGaughy R Kent Jr — Director | Conversion (C): 7,074,608 · Conversion (C): 954,182 · Purchase (P): 450,000 @ $20 · Conversion (C): 5,895,507 (derivative) @ $0 · Conversion (C): 795,152 (derivative) @ $0 | EDGAR |
Recent 8-K events — Instil Bio, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-31 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TIL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs